Literature DB >> 20605742

House dust mite allergens in asthma and allergy.

Wayne R Thomas1, Belinda J Hales, Wendy-Anne Smith.   

Abstract

IgE antibodies in house dust mite (HDM) allergy follow a predictable pattern. Half are directed against two dominant allergens and the remainder largely against four midpotency allergens. This hierarchical pattern is not changed by the titre of the IgE response or severity of disease. The structures of these allergens are known and they can be produced as authentic recombinant allergens. There is also evidence that the allergenicity is augmented by the biological activity of the key allergens, validating them as targets for vaccination. Collectively, these developments should facilitate the development of new diagnostics, improve immunotherapy and allow vaccination with defined reagents. Highly purified recombinant polypeptides representing the important mite allergens are now available so that informative and reproducible experiments can be performed with mite allergens in place of poorly defined and variable extracts. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605742     DOI: 10.1016/j.molmed.2010.04.008

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  80 in total

1.  Molecular determinants for antibody binding on group 1 house dust mite allergens.

Authors:  Maksymilian Chruszcz; Anna Pomés; Jill Glesner; Lisa D Vailes; Tomasz Osinski; Przemyslaw J Porebski; Karolina A Majorek; Peter W Heymann; Thomas A E Platts-Mills; Wladek Minor; Martin D Chapman
Journal:  J Biol Chem       Date:  2011-12-30       Impact factor: 5.157

2.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

3.  Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.

Authors:  Jinhong Zhao; Chaopin Li; Beibei Zhao; Pengfei Xu; Haifeng Xu; Lianping He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation.

Authors:  Ignacio J Juncadella; Alexandra Kadl; Ashish K Sharma; Yun M Shim; Amelia Hochreiter-Hufford; Larry Borish; Kodi S Ravichandran
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

5.  Effect of stored product mite extracts on human dermal microvascular endothelial cells.

Authors:  B Laurel Elder; Marjorie S Morgan; Larry G Arlian
Journal:  J Med Entomol       Date:  2012-11       Impact factor: 2.278

6.  Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.

Authors:  Zhiming Liu; Yuxin Jiang; Chaopin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 7.  Recombinant allergens: the present and the future.

Authors:  Marek Jutel; Katarzyna Solarewicz-Madejek; Sylwia Smolinska
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

8.  Epigenetic alterations by DNA methylation in house dust mite-induced airway hyperresponsiveness.

Authors:  Yan Shang; Sandhya Das; Richard Rabold; James S K Sham; Wayne Mitzner; Wan-yee Tang
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

9.  Characterization of Der f 29, a new allergen from dermatophagoides farinae.

Authors:  Congli Jiang; Xiaoqin Fan; Meng Li; Peng Xing; Xiaoyu Liu; Yulan Wu; Min Zhang; Pingchang Yang; Zhigang Liu
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

10.  The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.

Authors:  Pavle S Milutinovic; John F Alcorn; Judson M Englert; Lauren T Crum; Tim D Oury
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.